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A B S T R A C T
Background. Donor kidneys contain a large reservoir of passenger leucocytes that contribute to acute rejection via direct alloantigen presentation and pro-inflammatory cytokine secretion. However, the early contribution of these cells following revascularization has not previously been described. We performed a secondary, high-volume preservation flush following cold storage to characterize the inflammatory contribution of the donor kidney upon reperfusion. Methods. Porcine kidneys were retrieved using a protocol analogous to current UK clinical practice. Following 2 h of cold static preservation, kidneys underwent a secondary flush with Ringer's solution. The venous effluent was collected and leucocytes phenotyped via flow cytometry. Inflammatory mediators, including cytokines and cell-free DNA, were then assessed to determine the inflammatory contribution of the donor kidney. . Within this population, T cells were dominant, representing >60% of the leucocyte repertoire. Granulocytes, monocytes and natural killer cells were also identified, but in comparatively lower numbers. Significant concentrations of cytokines and cell-free DNA were also eluted upon reperfusion. Conclusions. The donor kidney contains a significant immune load that rapidly mobilizes following reperfusion. Performing a secondary preservation flush prior to implantation may reduce this inflammatory burden via diversion of donor leucocytes and inflammatory mediators from entry into the recipient circulation. This may modulate direct presentation and reduce the inflammatory contribution of the donor kidney following transplantation. Key words: acute rejection, immunogenicity, kidney transplantation, passenger leucocyte, preservation
I N T R O D U C T I O N
Kidney transplantation is the optimal treatment option for patients with end-stage renal disease. However, the limited availability of donor organs suitable for transplant coupled with the combined effects of ischaemia-reperfusion injury and acute rejection (AR) represent major barriers to successful transplantation. Donor-derived leucocytes are integral to the allorecognition of transplanted organs and may stimulate both the innate and adaptive immune response. We have previously demonstrated that removing donor leucocytes through ex vivo normothermic perfusion reduces graft immunogenicity and can impede AR in the absence of immunosuppression [1] . However, our understanding of the immunological and proinflammatory contribution of the donor kidney upon transplantation is limited and warrants investigation.
The donor kidney houses a significant immune compartment consisting of T cells, B cells, natural killer (NK) cells and professional antigen-presenting cells (APCs). The majority of these donor leucocytes are marginal and have the capacity to rapidly mobilize into the recipient circulation following revascularization [2] . Here, they can directly present alloantigen to recipient naïve T cells via donor major histocompatibility complex (MHC) and induce antigen-specific clonal expansion. Ultimately this drives immunological rejection against alloantigens expressed on the graft. In current clinical practice, an in situ preservation flush of the donor vascular tree is performed at the donor hospital site, washing blood from the vasculature of the organ. The organ, flushed and core cooled, is then stored on ice for transport. At the recipient hospital, the organ is then typically implanted following immediate removal from the ice. In some instances, the donor kidney is flushed again prior to implantation, particularly where residual microsurgical blood traces are suspected; however, this is not ubiquitously practiced and the implications post-transplantation remain unclear.
The robust donor immune compartment contained within the kidney is, therefore, usually transplanted into the recipient. In combination with a preservation strategy, which leaves this resident leucocyte population intact, organ parenchymal cells become damaged during the process of donor death and subsequent cold storage. This results in significant cellular injury and a global inflammatory response in the donor. Together, these processes increase the immunogenicity of the organ before transplantation, leading to an increased risk of delayed graft function and AR.
Performing a secondary flush of the donor kidney following static cold storage (SCS) on ice immediately prior to implantation provides the opportunity to characterize the events that occur immediately upon revascularization. In addition, this technique may remove passenger leucocytes and inflammatory mediators that would typically be transferred into the recipient circulation. For this purpose, kidneys were retrieved using solutions and perfusion protocols analogous to clinical practice in the UK [3] and stored on ice. A subsequent secondary preservation flush was performed and the cellular effluent analysed. Given that direct presentation alone can drive AR, reducing the transfer of donor leucocytes prior to transplantation may impact on rejection and graft survival [4] .
M A T E R I A L S A N D M E T H O D S

Organ procurement
Kidneys from 8 Landrace pigs [n ¼ 5 for the main study and an additional n ¼ 3 for regulatory T cell (Treg) assessment] with a mean dry weight of 80 kg were retrieved as previously described [2] . All pigs were culled in accordance with the European Union Council Regulation (EC) 1099/2009 on the protection of animals at the time of killing. Briefly, pigs were veterinary inspected and then sacrificed via electrical stunning followed by an incision of the carotid artery, representing a donation after circulatory death (DCD) model. A midline incision was performed and kidneys were immediately excised and placed on ice. Following inspection for evidence of disease or injury, the renal artery and ureter were isolated and cannulated. The renal artery was flushed with 20 mL glyceryl trinitrate followed by a standardized 1-L flush of 4 C Marshall's hypertonic citrate (Soltran, Baxter Healthcare, Thetford, UK) supplemented with 10 000 IU unfractionated heparin (to aid clot dissemination). The pressure of the preservation flush did not exceed 100 mmHg. Kidneys were then submerged in Soltran and placed on ice for transport.
Secondary preservation flush
Following 2 h of SCS, kidneys were removed from ice and placed onto a porous platform within a venous reservoir. A clinical-grade giving set (Baxter Healthcare, Thetford, UK) was then attached to the renal artery. The vasculature of the kidney was flushed with 2 L of room temperature Ringer's solution. This is an isotonic, physiological solution that does not impact cellular viability and remains the solution of choice for pre-flushing kidneys prior to ex vivo normothermic perfusion [5] . The venous outflow drained into the reservoir and the venous effluent was collected. The ureter cannula was placed into a separate measuring cylinder to prevent contamination of the sample with filtered excretory tract fluid and to determine fluid loss via this route.
Sample processing
At the end of the preservation flush, the venous effluent was thoroughly mixed and 10 mL placed into a falcon tube. Samples were centrifuged at 2000 g for 2 min at 4 C and 200-mL aliquots of supernatant were removed and stored at À80
C. The remaining cell pellets were resuspended in 500-mL phosphate-buffered saline (PBS) split between four tubes and analysed by flow cytometry. For Tregs, cell pellets were resuspended in 100 mL of PBS in one tube.
Flow cytometry
Immunophenotyping of the preservation flush was performed on an LSR II flow cytometer (Becton Dickinson,
Oxford, UK). Leucocytes were identified and gated as CD45 þ and their viability determined using a Zombie UV viability dye (BioLegend, San Diego, CA, USA). From this, a panel of antibodies was utilized to characterize T helper cells
were also assessed in an additional three cell pellets in which fixation and permeabilization steps were included. Cells were treated with red blood cell lysing solution (BD Biosciences, Oxford, UK), washed and resuspended in 0.3 mL staining buffer. Finally, 20-mL 123count eBeads (ebioscience, San Diego, CA, USA) was added and samples were analysed for 2 min. All gating strategies and analysis were performed using FlowJo version 10.0.6.
Luminex analysis
The concentration of cytokines and chemokines within the second preservation flush was assessed using supernatant samples collected from the total effluent. A commercially available porcine 13-plex magnetic bead panel (Merck Millipore, Billerica, MA, USA) was utilized, following the manufacturer's protocol. The plate was read using a Bio-Plex 200 system (BioRad, Hertfordshire, UK).
Mitochondria isolation
To extract mitochondrial DNA (mtDNA) for quantitative polymerase chain reaction (qPCR) standards, mitochondria were isolated from porcine lung tissue using a mitochondrial isolation kit (ScienCell Research Laboratories, Carlsbad, CA, USA) under sterile conditions at 4 C.
DNA extraction
The QIAamp DNA Blood Mini Kit was used to extract cellfree DNA from supernatant samples of the flush according to the manufacturer's protocol (Qiagen, Manchester, UK). Genomic DNA (gDNA) was extracted from porcine blood and mtDNA from isolated mitochondria to generate a standard curve during qPCR.
qPCR qPCR was performed to determine the presence of cell-free (extracellular) DNA. All primers used for qPCR were designed using the Primer Express software version 3.0.1 (Life Technologies, Paisley, UK) and their homology assessed using BLAST. Primers (Sigma Aldrich, Dorset, UK) designed for mtDNA (cytochrome B) were adjusted to 25 nM and for gDNA (glyceraldehyde-3-phosphate dehydrogenase) to 50 nM using nuclease-free water (Ambion, Thermo Fisher Scientific, Waltham, MA, USA). All qPCR was performed using a QuantStudio 12 K Flex system (Life Technologies, Paisley, UK) with a Power SYBR green PCR master mix (Life Technologies, Paisley, UK).
Statistical analysis
All statistical analysis was carried out using SPSS software version 22 (IBM, Armonk, NY, USA). Data normality was determined using the Shapiro-Wilk test. Data are presented as mean [standard deviation (SD)]. For the comparison between gDNA and mtDNA, the independent samples t-test was utilized. Data were considered significantly different if a P-value < 0.05 was observed. All graphs were created using GraphPad Prism version 7.0 (GraphPad Software, La Jolla, CA, USA).
R E S U L T S
Organ procurement
All kidneys utilized were free from any immediate evidence of disease and injury. The time taken for organ retrieval (taken as the time from death to organ explant) was comparable between all pigs, averaging 3 (SD 0.71) min. The average warm ischaemic time (taken as the time from death to the start of the cold preservation flush) was 10 (SD 1.14) min. )] were also detected in abundance (Figure 2) . Tregs represented only a minor proportion (<0.05%) of the T cell repertoire (Figure 3 ). 
Total number of leucocytes
Cell-free mtDNA and gDNA
Within the total venous efflux, both mtDNA and gDNA were identified in high concentrations, with significantly more gDNA than mtDNA (P < 0.001; Figure 5 ).
D I S C U S S I O N
Donor kidneys possess a significant repertoire of leucocytes that are transferred into the recipient during transplantation [2] . These donor-derived leucocytes are intrinsically linked to the rejection process, with direct allorecognition alone capable of initiating AR [4] . In this study, we demonstrate that passenger leucocytes rapidly mobilize from the donor kidney upon revascularization. Within the venous effluent, the mean number of leucocytes that migrated from the donor kidney was 4.738 Â 10 8 (SD 1.348 Â 10 8
). Given that it is estimated a healthy kidney is perfused with 750 mL of blood per minute (or 20% of cardiac output), then these cells have the potential to rapidly mobilize into the recipient circulation upon reperfusion. Interestingly CD4 þ and CD8 þ T cells were the dominant population of leucocytes in the effluent. Given that donor CD4 þ T cells alone can drive a major alloreactive response and are essential for early AR [6] , removal of this population of cells is likely to be of benefit. As expected, the majority of T cells were inflammatory in nature, with only a minor population of Treg origin (representing <0.05% of the T cell repertoire). In addition, IL-10 was not detectable in the flush exudate. This was important to confirm, as donor Tregs and IL-10 are required for transplant tolerance, therefore their presence within the recipient circulation is proposed to be of benefit [7] .
Additional to T cells, APCs including large numbers of monocytes and B cells were also present. Following revascularization, donor monocytes rapidly mobilize to recipient lymph nodes and self-present donor antigens to naïve T cells, resulting in alloantigen-specific clonal expansion and infiltration of the graft [8] . A recipient T cell response is initiated, which manifests as AR. NK cells were also detected in the flush exudate, yet to date we have no definitive understanding of the role of donor NK cells following transplantation. Recipient NK cells can contribute to graft rejection via direct recognition of alloantigen, resulting in cytolytic activation and pro-inflammatory cytokine secretion [9] . Conversely, recipient NK cells have been reported to reduce the inflammatory burden immediately following transplantation by killing donor leucocytes [6] . Indeed, there is evidence of tolerance and graft acceptance induced by recipient NK cell killing of donor dendritic cells (DCs) [10, 11] . It is also possible that donor NK cells may kill recipient leucocytes; however, the impact of this remains unknown. The potential roles of donor NK cells and the impact of their removal prior to transplantation needs detailed investigation.
Aside from leucocytes, IFN-c was also present within the effluent following a secondary flush. IFN-c is a major proinflammatory cytokine that contributes to graft immunogenicity through up-regulation of donor MHC class I, which accelerates allorecognition. IFN-c also contributes to chemotaxis via the IFN-c-chemokine axis, enabling both donor leucocyte mobilization and recipient infiltration of the kidney [12, 13] . Indeed, IFN-c is capable of inducing CXCL-10 secretion, a chemokine with potent T cell chemotactic properties [14] . This may explain the significant population of T cells present within the secondary preservation flush. CXCL-8 was also detected, which further contributes to donor and recipient leucocyte mobilization. Interestingly, CXCL-8 has also been implicated in reperfusion injury, with anti-CXCL-8 antibodies preventing injury [15] . Although only minor concentrations of IL-1b and IL-18 were detected within the exudate, these inflammasomerelated cytokines are associated with inflammation and apoptosis post-transplantation and have a key role in inducing adaptive immune responses [13, 16] .
While the source of the cytokines and chemokines cannot be determined from this study, we propose that cellular injury causes intracellular components to be present in the extracellular spaces. This will activate donor leucocytes during SCS and induce cytokine secretion. Significant quantities of cell-free gDNA and mtDNA were identified within the flush exudate, which have well-reported inflammatory effects. Both gDNA and mtDNA initiate alloreactivity via ligation of toll-like receptors (TLRs) on both donor and recipient DCs and macrophages (m/). TLR ligation induces the up-regulation of co-stimulatory molecules on DCs and m/, which is essential for the allospecific clonal expansion of recipient T cells. The source of extracellular DNA is unclear but the impact of SCS on graft function is well established, with increasing cold ischaemic times enhancing the risk of graft failure due to a loss of tissue viability [17] . Indeed, cold ischaemic times may also influence the inflammatory profile of the donor kidney, and this clearly warrants further investigation. This study demonstrates that DCD donor kidneys contain a significant immune and inflammatory compartment, the characteristics of which drive pro-inflammatory responses following revascularization. Removing a proportion of passenger leucocytes via a secondary flush immediately prior to transplantation may therefore have the potential to impact upon allorecognition and AR. It should be noted, however, that the impact of donation after brain death on the inflammatory profile of donor kidneys was not determined in this study, and this may significantly alter the profile described herein. The extent of immunodepletion and the impact that reducing recipient exposure to donor leucocytes has on patient outcomes also remains unclear and requires additional studies. Finally, the optimal flush volume required to reduce leucocyte content from the donor organ without impacting on graft viability needs to be determined. The arbitrary volume of 2 L was chosen for this study to represent the initial reperfusion period, ensuring that the kidney underwent two full perfusion cycles (750 mL/min). In addition, flushing with this volume did not significantly impact on cold ischaemic times, meaning this has the potential to be utilized clinically. Despite this, performing a secondary flush immediately prior to implantation may represent a cost-effective and clinically viable therapeutic intervention for DCD kidneys.
Our findings clearly warrant further investigation using a large animal transplant model to determine if reducing the inflammatory burden of the kidney impacts on clinical outcome.
If the expected benefit can be demonstrated, then a clinical trial of this method should be performed to provide translational evidence.
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